The Science of Goji Weight Loss
Goji Weight Loss' unique, triple patent pending formula, combines only the most effective, scientifically-supported natural ingredients, in the exact potencies recommended by the latest research. To learn more about Goji Weight Loss' contributing nutrients, or to find additional product information, please reference the sources cited below.*Advantage Price - The Advantage Price involves enrolling in the Monthly Autoship Advantage Program. You will be sent your product every month on the 21st unless you skip your order for the month or until you cancel your order. You can cancel your Advantage order at anytime.
Amagase H, et al. Controlling Waist Circumference and Enhancing Resting Metabolic Rate by Lycium barbarum (Goji) Juice Intake in the Humans. (in preparation).
Amagase H, et al. Immunomodulatory Effects of a Standardized Lycium barbarum Fruit Juice in Chinese Older Healthy Human Subjects. J Med Foods (in press).
Amagase H, et al. Lycium barbarum (goji) juice shows significant in vivo antioxidant effects in human serum in a randomized, double-blind, placebo-controlled clinical study. Nutr Res (in press).
Amagase H, et al. Clinical studies of improving general well-being by a standardized Lycium barbarum fruit juice. Planta Med 2008; 74: 1-338.
Amagase H, et al. Improvement of sleep quality by a standardized Lycium barbarum fruit juice shown in a randomized, double-blind, placebo-controlled clinical study. Planta Med 2008; 74: 1-338.
Kishimoto Y, et al. Effects of Long-term Administration of Indigestible Dextrin on Visceral Fat Accumulation. J. Jpn. Assoc. Dietary Fiber Res 2000;4(2):59-65.
Mizushima N, et al. Effect of long-term ingestion of indigestible dextrin-containing soft drinks on safety and blood glucose levels. J. Nutritional Food 2000;3(3):75-82.
Wolf BW, et al. Glycemic response to a rapidly digested starch is not affected by the addition of an indigestible dextrin in humans. Nutrition Research 2001:21:1099-1106.
Fastinger ND, et al. A Novel Resistant Maltodextrin Alters Gastrointestinal Tolerance Factors, Fecal Characteristics, and Fecal Microbiota in Healthy Adult Humans. J Amer Col Nutrition 2008;27(2):356-366.
Pohle-Krauza RJ, et al. Effects of L-phenylalanine on energy intake in overweight and obese women: interactions with dietary restraint status. Appetite 2008;51(1):111-119.
Medeiros MA, et al. A reassessment of the role of serotonergic system in the control of feeding behaviour. An Acad Bras Cienc 2005;77(1):103-111.
Schulpis KH, et al. Morning preprandial plasma ghrelin and catecholmine concentrations in patients with phenylketonuria and normal controls: evidence for catecholamine-mediated ghrelin regulation. J Clin Endocrinol Metab 2004;89(8):3983-3987.
Santini F, et al. Genetic screening for melanocortin-4 receptor mutations in a cohort of Italian obese patients: description and functional characteristics of a novel mutation. J Clin Endocrinol 2004;89(2):904-908.
Nickolls SA, et al. Molecular determninants of melanocortin 4 receptor ligand binding and MC4/MC3 receptor selectivity. J Pharmacol Exp Ther 2003;304(3):1217-1227.
Chavey C, et al. Matrix metalloproteinases are differentially expressed in adipose tissue during obesity and modulate adipocyte differentitation. J Biol Chem 2003;278(14):11888-11896.
Rosenberry AG, et al. Decreased vesicular somatodendritic dopamine stores in leptin-deficient mice. J Neurosci 2007;27(26):7021-7027.
Pohle-Krauza RJ, et al. Dietary restraint and menstral cycle phase modulated L-phenylalnine-induced satiety. Physiol Behav 2008;93(4-5):851-861.
Hoeger WW, et al. Four-week supplementation with a natural dietary compound produces favorable changes in body composition. Adv Ther 1998;15(5):305-314.
Neri DF, Wiegmann D, Stanny RR, et al. The effects of tyrosine on cognitive performance during extended wakefulness. Aviat Space Environ Med 1995;66:313-9.
Durlach PJ. The effects of a low dose of caffeine on cognitive performance. Psychopharmacology (Berl) 1998;140:116-9.
Hindmarch I, Quinlan PT, Moore KL, Parkin C. The effects of black tea and other beverages on aspects of cognition and psychomotor performance. Psychopharmacol 1998;139:230-8.
Kamimori GH, Penetar DM, Headley DB, et al. Effect of three caffeine doses on plasma catecholamines and alertness during prolonged wakefulness. Eur J Clin Pharmacol 2000;56:537-44.
Warburton DM, Bersellini E, Sweeney E. An evaluation of a caffeinated taurine drink on mood, memory and information processing in healthy volunteers without caffeine abstinence. Psychopharmacology (Berl) 2001;158:322-8.
Scholey AB, Kennedy DO. Cognitive and physiological effects of an "energy drink:" an evaluation of the whole drink and of glucose, caffeine and herbal flavouring fractions. Psychopharmacology (Berl) 2004;176:320-30.
Greer F, Friars D, Graham TE. Comparison of caffeine and theophylline ingestion: exercise metabolism and endurance. J Appl Physiol 2000;89:1837-44.
Breum L, Pedersen JK, Ahlstrom F, et al. Comparison of an ephedrine/caffeine combination and dexfenfluramine in the treatment of obesity. A double-blind multi-centre trial in general practice. Int J Obes Relat Metab Disord 1994;18:99-103.
Toubro S, Astrup A, Breum L, Quaade F. The acute and chronic effects of ephedrine/caffeine mixtures on energy expenditure and glucose metabolism in humans. Int J Obes Relat Metab Disord 1993;17:S73-7.
Toubro S, Astrup A. Randomised comparison of diets for maintaining obese subjects' weight after major weight loss: ad lib, low fat, high carbohydrate diet v fixed energy intake. BMJ 1997;314:29-34.
Boozer CN, Daly PA, Homel P, et al. Herbal ephedra/caffeine for weight loss: a 6-month randomized safety and efficacy trial. Int J Obes Relat Metab Disord 2002;26:593-604.